Health care expert Fred Goldstein of AMCP Podcast Powered by PopHealth Week sits down with Patrick Gleason, PharmD, assistant vice president for health outcomes at Prime Therapeutics, and Nick Friedlander, PharmD, clinical programs pharmacist also in the health outcomes division at Prime Therapeutics, to discuss the digital therapeutics landscape.
Sponsored webinar that discussed Parkinson’s Disease psychosis and the many considerations regarding antipsychotic treatment in these patients from the payer perspective.
Legislative and Regulatory Position: AMCP believes that to provide the greatest value to Americans who need prescription drugs, market forces must effectively ensure that manufacturers of similar drugs compete with one another to establish reasonable pricing levels and maintain consumer access to needed therapies. While government has a responsibility to protect consumers against anti-competitive activity, the government must not establish rules that have the unintended effect of undermining competition.
Where We Stand: AMCP supports the use of MAC pricing as a managed care tool to encourage the dispensing of cost saving generic drugs and thereby benefiting the overall health care system.
Sponsored webinar that reviewed real-world data related to the impact of comorbidities, including: increased comorbid risks due to oral corticosteroid use, polypharmacy and resulting treatment complexity, and benefits of medication synchronization.